Page 214 - நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Calliditas announces final outcome of simplified mandatory offer to the shareholders of Genkyotex STOCKHOLM, Dec. 16, 2020 /PRNewswire/ Calliditas Therapeutics AB (publ) ( Calliditas ) (Nasdaq OMX - CALTX; NASDAQ - CALT) submitted a simplified public mandatory offer to the shareholders of Genkyotex on 26 November 2020. After the end of the acceptance period on December 11, Calliditas now controls 86.2 percent of the shares in Genkyotex. Calliditas acquired 7,236,515 ordinary shares in Genkyotex SA ( Genkyotex ) (Euronext Paris & Brussels: FR0013399474 - GKTX) on November 3, 2020, corresponding to 62.7 percent of the share capital and voting rights, from Genkyotex s largest shareholders and management group. On November 26, 2020, Calliditas submitted a simplified public mandatory cash offer of EUR 2.80 and non-transferable contingent rights, per share to the remaining shareholders in Genkyotex. In the final outcome after the acceptance period, 2,885,161 shares have been tendered

United statesMarie galayGenkyotex euronextExchange commissionEuronext parisNasdaq stockholmNasdaq global select marketPrivate securities litigation reform actஒன்றுபட்டது மாநிலங்களில்பரிமாற்றம் தரகுநாஸ்டாக் ஸ்டாக்‌ஹோல்ம்நாஸ்டாக் உலகளாவிய தேர்ந்தெடுக்கவும் சந்தைப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம்